Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
- Author(s)
- Chen, DC; AlSaffar, H; Graefen, H; Perera, S; Mazzone, E; Perera, ML; Lawrentschuk, N; Murphy, DG;
- Details
- Publication Year 2024-09,Volume 86,Issue #3,Page 282-283
- Journal Title
- European Urology
- Publication Type
- Commentary
- Publisher
- Elsevier
- Keywords
- Humans; *Antibodies, Monoclonal, Humanized/therapeutic use; *Carcinoma, Transitional Cell/drug therapy/pathology; *Antibodies, Monoclonal/therapeutic use; *Antineoplastic Agents, Immunological/therapeutic use/adverse effects; *Urinary Bladder Neoplasms/drug therapy/pathology; Urologic Neoplasms/drug therapy/pathology
- Department(s)
- Surgical Oncology
- Publisher's Version
- https://doi.org/10.1016/j.eururo.2024.03.032
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-09-26 03:32:06
Last Modified: 2024-09-26 03:32:20